老年非ST段抬高型急性冠脉综合征患者侵入性与保守策略的长期结局
After Eighty 研究将 457 例年龄≥80 岁的 NSTE-ACS 患者随机分配至侵入性策略或保守策略,中位随访 5.3 年后,侵入性策略在降低主要终点方面优于保守策略,5 年和 10 年无事件生存分别显著延长 276 天和 337 天。
要点
- 年龄≥80 岁的 NSTE-ACS 患者,侵入性策略较保守策略显著降低主要复合终点事件。
- 侵入性策略带来显著的无事件生存获益,5 年延长 276 天,10 年延长 337 天。
- 亚组分析显示,主要心血管预后因素各亚组结果一致。
核心结论
- 在年龄≥80 岁的 NSTE-ACS 患者中,侵入性策略在减少复合事件方面优于保守策略,并显著延长无事件生存。
研究设计与样本
- After Eighty 研究为随机对照试验(NCT01255540),于 2010 至 2014 年纳入 457 例年龄≥80 岁的 NSTE-ACS 患者(平均年龄 85 岁),随机分配至侵入性策略或保守策略。
主要发现
- 中位随访 5.3 年后,侵入性策略较保守策略显著降低主要终点(发生率比 0.76;95%CI 0.63-0.93;P=0.0057)。
- 侵入性策略在 5 年时无事件生存显著延长 276 天(95%CI 151-400 天;P=0.0001),10 年时延长 337 天(95%CI 123-550 天;P=0.0001)。
- 在主要心血管预后因素各亚组中,结果一致。
临床怎么用
- 对于年龄≥80 岁的 NSTE-ACS 患者,可考虑采用侵入性策略(早期冠状动脉造影并评估血运重建)以降低复合事件并延长无事件生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a frequent cause of hospital admission in older people, but clinical trials targeting this population are scarce. OBJECTIVES: The After Eighty Study assessed the effect of an invasive vs a conservative treatment strategy in a very old population with NSTE-ACS. METHODS: Between 2010 and 2014, the investigators randomized 457 patients with NSTE-ACS aged ≥80 years (mean age 85 years) to an invasive strategy involving early coronary angiography with immediate evaluation for revascularization and optimal medical therapy or to a conservative strategy (ie, optimal medical therapy). The primary endpoint was a composite of myocardial infarction, need for urgent revascularization, stroke, and death. The long-term outcomes are presented. RESULTS: After a median follow up of 5.3 years, the invasive strategy was superior to the conservative strategy in the reduction of the primary endpoint (incidence rate ratio: 0.76; 95% CI: 0.63-0.93; P = 0.0057). The invasive strategy demonstrated a significant gain in event-free survival of 276 days (95% CI: 151-400 days; P = 0.0001) at 5 years and 337 days (95% CI: 123-550 days; P = 0.0001) at 10 years. These results were consistent across subgroups of patients with respect to major cardiovascular prognostic factors. CONCLUSIONS: In patients aged ≥80 years with NSTE-ACS, the invasive strategy was superior to the conservative strategy in the reduction of composite events and demonstrated a significant gain in event-free survival. (The After Eighty Study: a randomized controlled trial; NCT01255540).
引用
- Berg, Tegn, Abdelnoor, et al. Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2023. PMID: 37968019. doi:10.1016/j.jacc.2023.09.809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。